OptimizeRx (OPRX) Earnings Date, Estimates & Call Transcripts $10.01 +0.10 (+1.01%) As of 05/9/2025 03:59 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock OptimizeRx Earnings Summary OptimizeRx released Q2 2024 earnings on August 8, 2024, reporting an EPS of -$0.14, which beat analysts' consensus estimates of -$0.25 by $0.11. Quarterly revenue was reported to be $18.81 million, below the consensus estimate of $20.47 million. With a trailing EPS of -$1.10, OptimizeRx's earnings are expected to grow next year, from ($0.33) to ($0.29) per share. Upcoming Q3 Earnings DateMay. 12EstimatedConsensus EPS (Aug. 8) -$0.25 Actual EPS (Aug. 8) -$0.14 Beat By $0.11 Actual Revenue (Aug. 8) $18.81MQ2 2024 Earnings ResourcesQ2 2024 Earnings ReportConference Call Transcript & Audio Quarterly Report (10-Q) Press Release (8-K)OPRX Upcoming EarningsOptimizeRx's Q1 2025 earnings is scheduled for Monday, May 12, 2025, with a conference call scheduled on Tuesday, May 13, 2025 at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get OptimizeRx Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on OptimizeRx and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataOPRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.OPRX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. OptimizeRx Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue GuidanceQ1 20251-$0.34-$0.34-$0.34Q2 20251-$0.18-$0.18-$0.18Q3 20251$0.05$0.05$0.05Q4 20251$0.19$0.19$0.19 FY 2025 4 -$0.28 -$0.28 -$0.28 Q1 20261-$0.19-$0.19-$0.19Q2 20261-$0.16-$0.16-$0.16Q3 20261-$0.05-$0.05-$0.05Q4 20261$0.44$0.44$0.44 OptimizeRx Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/12/2025(Estimated)--$0.11------8/8/2024Q2 2024-$0.25-$0.14+$0.11-$0.06$20.47M$18.81M5/14/2024Q1 2024-$0.11-$0.27 -$0.16-$0.16$18.66M$19.69M4/16/2024Q4 2023-$0.11+$0.11$0.45-$28.37M11/6/2023Q3 2023-$0.19-$0.10+$0.09-$0.03$15.07M$16.33M8/14/2023Q2 2023-$0.28-$0.21+$0.07-$0.18$14.97M$13.82M OptimizeRx Earnings - Frequently Asked Questions When is OptimizeRx's earnings date? OptimizeRx has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 12th, 2025 based off last year's report dates. Learn more on OPRX's earnings history. What guidance has OptimizeRx issued on next quarter's earnings? OptimizeRx updated its FY 2025 earnings guidance on Wednesday, March, 12th. The company issued revenue guidance of $100.0 million-$100.0 million, compared to the consensus revenue estimate of $99.7 million. Did OptimizeRx beat their earnings estimates last quarter? In the previous quarter, OptimizeRx (NASDAQ:OPRX) reported ($0.14) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.25) by $0.11. Learn more on analysts' earnings estimate vs. OPRX's actual earnings. How can I listen to OptimizeRx's earnings conference call? The conference call for OptimizeRx's latest earnings report can be listened to online. Listen to Conference Call How can I read OptimizeRx's conference call transcript? The conference call transcript for OptimizeRx's latest earnings report can be read online. Read Transcript How much revenue does OptimizeRx generate each year? OptimizeRx (NASDAQ:OPRX) has a recorded annual revenue of $92.13 million. How much profit does OptimizeRx generate each year? OptimizeRx (NASDAQ:OPRX) has a recorded net income of -$17.57 million. OPRX has generated -$1.10 earnings per share over the last four quarters. What is OptimizeRx's EPS forecast for next year? OptimizeRx's earnings are expected to grow from ($0.33) per share to ($0.29) per share in the next year. More Earnings Resources from MarketBeat Related Companies TIXT Earnings Results MAX Earnings Results NRDS Earnings Results THRY Earnings Results PRTH Earnings Results ACCD Earnings Results WLDN Earnings Results NVRI Earnings Results MEG Earnings Results DDI Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Nearly 20 Analysts Raised Meta Price Targets Post-EarningsOXY Stock Rebound Begins Following Solid Earnings BeatMonolithic Power Systems: Will Strong Earnings Spark a Recovery?Datadog Earnings Delight: Q1 Strength and an Upbeat Forecast Upwork's Earnings Beat Fuels Stock Rally—Is Freelancing Booming?DexCom Stock: Earnings Beat and New Market Access Drive Bull CaseDisney Stock Jumps on Earnings—Is the Magic Sustainable? This page (NASDAQ:OPRX) was last updated on 5/12/2025 by MarketBeat.com Staff From Our PartnersThis next market event could mean total financial ruin for someYou think the volatility is over? Think again … Because it’s just getting started. In fact, according...Weiss Ratings | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Man I Turn to In Times Like ThisA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredVanishing BenefitsWhat would you do if your next Social Security check simply never arrived? If you called and the line was d...Investors Alley | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon Warns “America Is Broke”. Trump’s Plan Inside.Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptimizeRx Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share OptimizeRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OPRX Stock Free OPRX Stock Alerts